Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 020949
Company: NORVIUM BIOSCIENCE
Company: NORVIUM BIOSCIENCE
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
ACCUNEB | ALBUTEROL SULFATE | EQ 0.042% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION;INHALATION | Discontinued | None | Yes | No |
ACCUNEB | ALBUTEROL SULFATE | EQ 0.021% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION;INHALATION | Discontinued | None | Yes | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
04/30/2001 | ORIG-1 | Approval | Type 5 - New Formulation or New Manufacturer | STANDARD |
Review
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/20-949_AccuNeb.cfm |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
04/28/2022 | SUPPL-27 | Labeling-Container/Carton Labels, Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020949Orig1s027lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/020949Orig1s027ltr.pdf | |
09/30/2013 | SUPPL-26 | Manufacturing (CMC) |
Label is not available on this site. |
||
09/30/2013 | SUPPL-25 | Manufacturing (CMC) |
Label is not available on this site. |
||
03/02/2011 | SUPPL-24 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020949s024lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020949s024ltr.pdf | |
06/02/2006 | SUPPL-11 | Labeling |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020949s011LTR.pdf |
11/13/2002 | SUPPL-9 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
08/06/2002 | SUPPL-7 | Manufacturing (CMC) |
Label is not available on this site. |
||
02/20/2002 | SUPPL-5 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
02/20/2002 | SUPPL-4 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
01/22/2002 | SUPPL-2 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
01/22/2002 | SUPPL-1 | Manufacturing (CMC)-Control |
Label is not available on this site. |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
04/28/2022 | SUPPL-27 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020949Orig1s027lbl.pdf | |
04/28/2022 | SUPPL-27 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020949Orig1s027lbl.pdf | |
03/02/2011 | SUPPL-24 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020949s024lbl.pdf |